Dario A. Paggiarino
Presently, Dario A. Paggiarino is Chief Medical Officer & Senior Vice President for EyePoint Pharmaceuticals, Inc.
In his past career Dr. Paggiarino occupied the position of President for Angelini Pharmaceuticals Romania SRL, Executive Director-Clinical Development at Pfizer Inc. Clinical Director at Pharmacia Corp. and Executive Director-Clinical Development at Pfizer (St. Louis) (both are subsidiaries of Pfizer Inc.), Chief Development Officer & Senior Vice President at Lpath, Inc. and Vice President at Alcon Laboratories, Inc.
He received a doctorate from Sapienza University of Rome.
|06/30/2020||12,049||Derivative/Non-derivative trans. at $0.76 per share.||9,158|
|06/30/2020||41,050||Derivative/Non-derivative trans. at $0 per share.||0|
|06/27/2020||2,936||Derivative/Non-derivative trans. at $0.79 per share.||2,320|
|06/27/2020||10,000||Derivative/Non-derivative trans. at $0 per share.||0|
|06/14/2020||4,168||Derivative/Non-derivative trans. at $0.83 per share.||3,460|
|06/14/2020||14,200||Derivative/Non-derivative trans. at $0 per share.||0|
|10/12/2019||2,450||Derivative/Non-derivative trans. at $2.1 per share.||5,145|
|06/27/2019||2,940||Derivative/Non-derivative trans. at $1.65 per share.||4,851|
|06/27/2019||10,000||Derivative/Non-derivative trans. at $0 per share.||0|
|06/14/2019||4,175||Derivative/Non-derivative trans. at $1.53 per share.||6,388|
|06/14/2019||14,200||Derivative/Non-derivative trans. at $0 per share.||0|
|03/19/2019||1,188||Derivative/Non-derivative trans. at $2.47 per share.||2,935|
|10/12/2018||2,455||Derivative/Non-derivative trans. at $3.23 per share.||7,930|
|10/12/2018||16,667||Award at $0 per share.||0|
|06/27/2018||2,945||Derivative/Non-derivative trans. at $1.86 per share.||5,478|
|06/27/2018||10,000||Derivative/Non-derivative trans. at $0 per share.||0|
|03/19/2018||8,333||Award at $0 per share.||0|